USPTO serial 76113832
ANTEROGEN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- DALIER, JOHN DAVID
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ANTEROGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Dongjak-ku, Seoul, KR
Dongjak-ku, Seoul, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
G. Roxanne Elings
G ROXANNE ELINGS GREENBERG TRAURIG, LLP885 THIRD AVENEW YORK, NY 10022-4834UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Agents for metabolism, namely, pharmaceutical preparations for the treatment of metabolism diseases; immune controlling agents, namely, pharmaceutical preparations for the treatment of disorders of the immune system; vaccines; biological pharmaceutical preparations for the regeneration of cartilage, bone and intervertebral disc tissue; drugs for allergies; diagnostic preparations for clinical or medical laboratory use; medical diagnostic reagents; hormones; preparations for the suppression of hormones; medical treatment for genes, namely, pharmaceutical preparations derived from patients for the treatment of circulatory diseases, gastrointestinal diseases and musculoskeletal system diseases | ACTIVE | — |
| 035 | Retail stores featuring medicines, health food supplements, and life science technologies, namely, genetic engineering, molecular biology, embryology and biochemistry; independent sales representative in the field of medicines, health food supplements, and life science technologies, namely genetic engineering, molecular biology, embryology and biochemistry; business data research, market research, agencies for export and import, business management advisory services | ACTIVE | — |
| 042 | Cellular tissue research, consultancy and testing; services relating to cellular tissue, namely, regeneration engineering; pharmaceutical preparations research, providing medicine information, life science research, biology research, product research and development for others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Anterogen Co. Ltd.
- Other trademarks owned by Anterogen Co. Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named ANTEROGEN
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 3, 2006 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 3, 2006 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 3, 2005 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 20, 2004 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Sep 8, 2004 | CFIT | CASE FILE IN TICRS | — |
| Mar 25, 2004 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 23, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 3, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 30, 2004 | FAXX | FAX RECEIVED | — |
| Jun 25, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 19, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 19, 2003 | PAPER RECEIVED | — | |
| Nov 21, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 1, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 1, 2002 | PAPER RECEIVED | — | |
| Aug 29, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 29, 2002 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jul 23, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 22, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2001 | DOCK | ASSIGNED TO EXAMINER | — |